How Path AI’s PathAssist Derm Tool Aims to Enhance Skin Cancer Diagnosis and Workflow Efficiency

Although the tool is currently designed for research use only, CEO Andy Beck, MD, PhD, is excited about its future in clinical dermatopathology.